Nucleolin Targeting Impairs the Progression of Pancreatic Cancer and Promotes the Normalization of Tumor Vasculature

Cancer Research - United States
doi 10.1158/0008-5472.can-16-0300
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

ERO1α Promotes Hypoxic Tumor Progression and Is Associated With Poor Prognosis in Pancreatic Cancer

Oncotarget
Oncology
2019English

HOXB9 Promotes Endometrial Cancer Progression by Targeting E2F3

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2018English

Targeting Breast Cancer Vasculature

2004English

miR-215 Promotes Malignant Progression of Gastric Cancer by Targeting RUNX1

Oncotarget
Oncology
2015English

Crosstalk Between Mast Cells and Pancreatic Cancer Cells Contributes to Pancreatic Tumor Progression

Clinical Cancer Research
Cancer ResearchOncology
2010English

Hypoxia-Inducible Factor-2α Promotes Tumor Progression and Has Crosstalk With WNT/Β-Catenin Signaling in Pancreatic Cancer

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2017English

Tumor-Specific Targeting of Pancreatic Cancer With Shiga Toxin B-Subunit

Molecular Cancer Therapeutics
Cancer ResearchOncology
2011English

Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease

Cancer Research
Cancer ResearchOncology
2015English

TGF-β Signaling Promotes Tumor Vasculature by Enhancing the Pericyte-Endothelium Association

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy